Astonea Labs [ASTONEALAB] vs Entero Healthcare [ENTERO] Detailed Stock Comparison

Astonea Labs

Entero Healthcare
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Astonea Labs wins in 10 metrics, Entero Healthcare wins in 7 metrics, with 0 ties. Astonea Labs appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Astonea Labs | Entero Healthcare | Better |
---|---|---|---|
P/E Ratio (TTM) | 34.59 | 49.64 | Astonea Labs |
Price-to-Book Ratio | 7.38 | 2.95 | Entero Healthcare |
Debt-to-Equity Ratio | 289.67 | 21.76 | Entero Healthcare |
PEG Ratio | N/A | 1.30 | N/A |
EV/EBITDA | 12.39 | 26.36 | Astonea Labs |
Profit Margin (TTM) | 5.49% | 1.90% | Astonea Labs |
Operating Margin (TTM) | 9.43% | 2.94% | Astonea Labs |
EBITDA Margin (TTM) | 9.43% | 2.94% | Astonea Labs |
Return on Equity | 35.35% | 5.36% | Astonea Labs |
Return on Assets (TTM) | 7.29% | 3.51% | Astonea Labs |
Free Cash Flow (TTM) | $-15.42M | $-881.80M | Astonea Labs |
1-Year Return | 28.04% | -17.14% | Astonea Labs |
Price-to-Sales Ratio (TTM) | 1.90 | 0.94 | Entero Healthcare |
Enterprise Value | $1.89B | $51.35B | Entero Healthcare |
EV/Revenue Ratio | 1.94 | 0.95 | Entero Healthcare |
Gross Profit Margin (TTM) | 22.53% | 9.94% | Astonea Labs |
Revenue per Share (TTM) | $126 | $1,242 | Entero Healthcare |
Earnings per Share (Diluted) | $5.09 | $23.55 | Entero Healthcare |
Astonea Labs vs Entero Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Astonea Labs | 1.15% | 0.00% | -1.94% | 22.23% | 28.89% | 28.89% |
Entero Healthcare | 1.40% | -5.30% | -10.01% | -2.28% | -1.16% | -21.13% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Astonea Labs | 28.04% | 28.04% | 28.04% | 28.04% | 28.04% | 28.04% |
Entero Healthcare | -17.14% | -1.50% | -1.50% | -1.50% | -1.50% | -1.50% |
News Based Sentiment: Astonea Labs vs Entero Healthcare
Astonea Labs
News based Sentiment: MIXED
September presented a mixed bag for Astonea Labs, with leadership changes and fluctuating stock performance occurring alongside a significant shift to a 'very expensive' valuation. While some positive investor participation was observed, the stock's underperformance and valuation concerns create a cautious outlook.
Entero Healthcare
News based Sentiment: MIXED
Entero Healthcare Solutions is demonstrating strong financial performance with impressive revenue and profit growth, as evidenced by the Q2 FY25 and Q1 FY26 results. However, the stock has experienced significant volatility and a decline over the past six months, creating a mixed investment picture. The upcoming investor meetings and Q3 2026 earnings report will be crucial to watch.
Performance & Financial Health Analysis: Astonea Labs vs Entero Healthcare
Metric | ASTONEALAB | ENTERO |
---|---|---|
Market Information | ||
Market Cap | ₹1.86B | ₹49.85B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 22,700 | 106,975 |
90 Day Avg. Volume | 25,167 | 83,414 |
Last Close | ₹176.00 | ₹1,148.20 |
52 Week Range | ₹135.00 - ₹185.00 | ₹1,080.00 - ₹1,584.25 |
% from 52W High | -4.86% | -27.52% |
All-Time High | ₹185.00 (Jul 22, 2025) | ₹1,584.25 (Nov 04, 2024) |
% from All-Time High | -4.86% | -27.52% |
Growth Metrics | ||
Quarterly Revenue Growth | N/A | 0.28% |
Quarterly Earnings Growth | N/A | 0.38% |
Financial Health | ||
Profit Margin (TTM) | 0.05% | 0.02% |
Operating Margin (TTM) | 0.09% | 0.03% |
Return on Equity (TTM) | 0.35% | 0.05% |
Debt to Equity (MRQ) | 289.67 | 21.76 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹23.85 | ₹396.70 |
Cash per Share (MRQ) | ₹0.11 | ₹73.09 |
Operating Cash Flow (TTM) | ₹92.50M | ₹-1,784,990,000 |
Levered Free Cash Flow (TTM) | ₹-124,626,128 | ₹948.20M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Astonea Labs vs Entero Healthcare
Metric | ASTONEALAB | ENTERO |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 34.59 | 49.64 |
Forward P/E | N/A | 22.40 |
PEG Ratio | N/A | 1.30 |
Price to Sales (TTM) | 1.90 | 0.94 |
Price to Book (MRQ) | 7.38 | 2.95 |
Market Capitalization | ||
Market Capitalization | ₹1.86B | ₹49.85B |
Enterprise Value | ₹1.89B | ₹51.35B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.94 | 0.95 |
Enterprise to EBITDA | 12.39 | 26.36 |
Risk & Other Metrics | ||
Beta | N/A | N/A |
Book Value per Share (MRQ) | ₹23.85 | ₹396.70 |
Financial Statements Comparison: Astonea Labs vs Entero Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ASTONEALAB | ENTERO |
---|---|---|
Revenue/Sales | ₹279.31M | ₹14.04B |
Cost of Goods Sold | ₹216.39M | ₹12.64B |
Gross Profit | ₹62.91M | ₹1.40B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹26.40M | ₹412.02M |
EBITDA | ₹37.02M | ₹558.96M |
Pre-Tax Income | ₹17.05M | ₹363.63M |
Income Tax | ₹4.58M | ₹61.31M |
Net Income (Profit) | ₹12.48M | ₹302.32M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ASTONEALAB | ENTERO |
---|---|---|
Cash & Equivalents | ₹881,000 | ₹2.29B |
Total Current Assets | ₹708.50M | ₹20.76B |
Total Current Liabilities | ₹629.45M | ₹8.45B |
Long-Term Debt | ₹216.62M | ₹670.18M |
Total Shareholders Equity | ₹184.13M | ₹17.70B |
Retained Earnings | ₹106.92M | ₹638.28M |
Property, Plant & Equipment | ₹43.19M | ₹1.64B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ASTONEALAB | ENTERO |
---|---|---|
Operating Cash Flow | ₹53.27M | N/A |
Capital Expenditures | ₹-21.82M | N/A |
Free Cash Flow | ₹42.57M | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ASTONEALAB | ENTERO |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 22,700 | 106,975 |
Average Daily Volume (90 Day) | 25,167 | 83,414 |
Shares Outstanding | 10.51M | 43.51M |
Float Shares | 1.75M | 11.24M |
% Held by Insiders | 0.86% | 0.63% |
% Held by Institutions | 0.03% | 0.21% |
Dividend Analysis & Yield Comparison: Astonea Labs vs Entero Healthcare
Metric | ASTONEALAB | ENTERO |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |